Home » FDA Weighs How to Apply Real-World Evidence to Regulatory Calls
FDA Weighs How to Apply Real-World Evidence to Regulatory Calls
The FDA is clarifying how it plans to evaluate real-world evidence to determine when it could be used to support regulatory decisions for medical devices.
Real-world data collected from sources outside of traditional trials, including retrospective studies, registries, electronic health records and other sources, could provide enough evidence for regulatory decisions; the FDA said in draft guidance.
Although real-world evidence gathered from real-world data elements could constitute valid scientific evidence, the agency said, it is not changing its evidentiary standards in any way. — Tamra Sami
Upcoming Events
-
11Jul
-
18Jul
-
21Oct